CastleArk Alternatives’s Incyte INCY Stock Holding History

CastleArk Alternatives’s Portfolio INCY Stock Details INCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,660	Closed	-$114K	–	140
2021 Q3	$114K	Buy	+1,660	New	+$126K	﹤0.01%	313

Other funds holding INCY

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CastleArk Alternatives's INCY Position: Q4 2021 in Review

CastleArk Alternatives sold out of Incyte (INCY) in Q4 2021, closing a stake of 1,660 shares — an estimated $114K sold.

CastleArk Alternatives first reported a position in INCY in Q3 2021 and held it in 1 quarter. The position peaked at $114K in Q3 2021. 526 funds tracked by Wall St. Rank hold INCY as of Q4 2021.

CastleArk Alternatives reported no remaining Incyte position as of Q4 2021 after selling out during the quarter.
CastleArk Alternatives sold 1,660 Incyte shares in Q4 2021, an estimated $114K.
CastleArk Alternatives first reported a position in Incyte in Q3 2021 and held it in 1 quarter.
CastleArk Alternatives's Incyte position peaked at $114K in Q3 2021.
526 funds tracked by Wall St. Rank held Incyte as of Q4 2021.

Based on CastleArk Alternatives's 13F filing for Q4 2021, filed 18 Feb 2022.